Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 38Neoplasm Metastasis 9Brain Neoplasms 6Stomach Neoplasms 3Colorectal Neoplasms 3Advanced Breast Cancer 3Triple Negative Breast Neoplasms 2Recurrence 2Neoplasms 2Neoplasm, Residual 2Meningeal Carcinomatosis 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Cancer With Brain Metastasis 2Salivary Gland Neoplasms 1Rectal Neoplasms 1Ovarian Neoplasms 1Inflammatory Breast Neoplasms 1HER2-positive Breast Cancer 1HER2-negative Breast Cancer 1HER2 Overexpression 1Glioblastoma 1Gastric Adenocarcinoma 1Drug-Related Side Effects and Adverse Reactions 1Colonic Neoplasms 1Breast Cancer Metastatic 1Adenocarcinoma Of Esophagus 1

Interventions

Fulvestrant 5dalpiciclib 3Letrozole 3ribociclib 2palbociclib 2fluzoparib 2exemestane 2apatinib 2Anastrozole 2trastuzumab deruxtecan 1sacituzumab govitecan 1pyrotinib 1pegfilgrastim 1patritumab deruxtecan 1olaparib 1irinotecan sucrosofate 1abemaciclib 1Zoledronic Acid 1Rogaratinib 1Patient Reported Outcome Measures 1Paclitaxel 1Neoadjuvant Therapy 1Liposomes 1Irinotecan 1Ga(III)-DOTATOC 1Everolimus 1Cell Separation 1Capecitabine 1Bevacizumab 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Breast Cancer Metastatic × trastuzumab deruxtecan × Clear all
NCT06750484 2026-05-06

Trial of Trastuzumab Deruxtecan in Previously Treated HER2

Yale University

Phase 2 Recruiting
40 enrolled
Breast

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡